These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28159408)

  • 1. BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients.
    Eoh KJ; Park JS; Park HS; Lee ST; Han J; Lee JY; Kim SW; Kim S; Kim YT; Nam EJ
    Gynecol Oncol; 2017 Apr; 145(1):137-141. PubMed ID: 28159408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Spectrum of
    Foglietta J; Ludovini V; Bianconi F; Pistola L; Reda MS; Al-Refaie A; Tofanetti FR; Mosconi A; Minenza E; Anastasi P; Molica C; Stracci F; Roila F
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review.
    Kwon BS; Byun JM; Lee HJ; Jeong DH; Lee TH; Shin KH; Suh DS; Kim KH
    Cancer Res Treat; 2019 Jul; 51(3):941-950. PubMed ID: 30309222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the Likelihood of Carrying a
    Ang BH; Ho WK; Wijaya E; Kwan PY; Ng PS; Yoon SY; Hasan SN; Lim JMC; Hassan T; Tai MC; Allen J; Lee A; Taib NAM; Yip CH; Hartman M; Lim SH; Tan EY; Tan BKT; Tan SM; Tan VKM; Ho PJ; Khng AJ; Dunning AM; Li J; Easton DF; Antoniou AC; Teo SH
    J Clin Oncol; 2022 May; 40(14):1542-1551. PubMed ID: 35143328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
    Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
    Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The integration of BRCA testing into oncology clinics.
    Percival N; George A; Gyertson J; Hamill M; Fernandes A; Davies E; Rahman N; Banerjee S
    Br J Nurs; 2016 Jun; 25(12):690-4. PubMed ID: 27345073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of patient age on breast cancer risk prediction models.
    Coopey SB; Acar A; Griffin M; Cintolo-Gonzalez J; Semine A; Hughes KS
    Breast J; 2018 Jul; 24(4):592-598. PubMed ID: 29316072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants.
    Jervis S; Song H; Lee A; Dicks E; Tyrer J; Harrington P; Easton DF; Jacobs IJ; Pharoah PP; Antoniou AC
    J Med Genet; 2014 Feb; 51(2):108-13. PubMed ID: 24277755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
    Armstrong K; Micco E; Carney A; Stopfer J; Putt M
    JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious BRCA1/2 mutations in an urban population of Black women.
    Lynce F; Smith KL; Stein J; DeMarco T; Wang Y; Wang H; Fries M; Peshkin BN; Isaacs C
    Breast Cancer Res Treat; 2015 Aug; 153(1):201-9. PubMed ID: 26250392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.
    Puski A; Hovick S; Senter L; Toland AE
    J Genet Couns; 2018 Sep; 27(5):1291-1301. PubMed ID: 29594659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.
    de Freitas Ribeiro AA; Junior NMC; Dos Santos LL
    Eur J Med Res; 2024 Mar; 29(1):187. PubMed ID: 38504328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision aids for female BRCA mutation carriers: a scoping review.
    McGarrigle SA; Prizeman G; Spillane C; Byrne N; Drury A; Polus M; Mockler D; Connolly EM; Brady AM; Hanhauser YP
    BMJ Open; 2024 Jun; 14(6):e076876. PubMed ID: 38871662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual BRCA mutation distribution in a high risk cancer genetics clinic.
    Nelson-Moseke AC; Jeter JM; Cui H; Roe DJ; Chambers SK; Laukaitis CM
    Fam Cancer; 2013 Mar; 12(1):83-7. PubMed ID: 23179792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.
    Pooley KA; McGuffog L; Barrowdale D; Frost D; Ellis SD; Fineberg E; Platte R; Izatt L; Adlard J; Bardwell J; Brewer C; Cole T; Cook J; Davidson R; Donaldson A; Dorkins H; Douglas F; Eason J; Houghton C; Kennedy MJ; McCann E; Miedzybrodzka Z; Murray A; Porteous ME; Rogers MT; Side LE; Tischkowitz M; Walker L; Hodgson S; Eccles DM; Morrison PJ; Evans DG; Eeles RA; Antoniou AC; Easton DF; Dunning AM;
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1018-24. PubMed ID: 24642354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
    Manchanda R; Burnell M; Gaba F; Sanderson S; Loggenberg K; Gessler S; Wardle J; Side L; Desai R; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    BJOG; 2019 May; 126(6):784-794. PubMed ID: 30767407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
    Werner-Lin A; Rubin LR; Doyle M; Stern R; Savin K; Hurley K; Sagi M
    Fam Syst Health; 2012 Jun; 30(2):166-80. PubMed ID: 22709328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
    Rahman B; Lanceley A; Kristeleit RS; Ledermann JA; Lockley M; McCormack M; Mould T; Side L
    J Med Genet; 2019 Mar; 56(3):195-198. PubMed ID: 29535157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging and complex decisions in the management of the BRCA mutation carrier.
    Stan DL; Shuster LT; Wick MJ; Swanson CL; Pruthi S; Bakkum-Gamez JN
    J Womens Health (Larchmt); 2013 Oct; 22(10):825-34. PubMed ID: 23987739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.
    Gray SW; Hornik RC; Schwartz JS; Armstrong K
    Clin Genet; 2012 Jan; 81(1):29-37. PubMed ID: 21992449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.